EGFR and cancer: Additionally, as a crucial regulator of survival, cell cycle arrest, and apoptosis of cancer cells, the NF-κB signaling pathway has not only been linked to the oncogenic potential of the EGFR but is also involved in the acquisition of EGFR-TKIs resistance [39,51].